Clinical Trials Directory

Trials / Completed

CompletedNCT03806582

Effect of a Higher Blood-pressure on Right Ventricular Function

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Frisius Medisch Centrum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Right ventricular (RV) dysfunction in cardiac surgery is an independent risk factor for morbidity and mortality. Raising the systemic blood pressure with norepinephrine seems to have a positive influence on the right ventricular function in several animal studies. The current study is designed to evaluate the effect of a higher blood pressure on the RV function in post cardiac surgery patients.

Detailed description

Goal: To demonstrate differences in RV function by raising the systemic blood pressure with norepinephrine. Study design: randomized controlled trial Study population: 78 postoperative cardiac surgery patients admitted at the ICU. Intervention: * Group 1: (N=22): RVEF\<20% and MAP≤65mmHg. Intervention with norepinephrine to reach a MAP of 85mmHg for a maximum duration of two hours. * Group 2: (N=22): RVEF \<20% and MAP≤65mmHg. Control group: treatment according to current standards. Hypotensive patients are treated with fluids and/or vasopressors to gain a mean arterial pressure (MAP) of 65mmHg. * Group 3: (N=17): RVEF between ≥20 and \<30% and MAP ≤65mmHg. Intervention with norepinephrine to reach a MAP of 85mmHg for a maximum duration of two hours. * Group 4: (N=17): RVEF between ≥20 and \<30% and MAP ≤65mmHg. Control group: treatment according to current standards. Hypotensive patients are treated with fluids and/or vasopressors to gain a mean arterial pressure (MAP) of 65mmHg. Endpoints: Primary endpoint is the difference between the intervention and the control group in the change over time between baseline and the end of the study period (T4) in RVEF. Secondary endpoints are the echocardiographic parameters of RV and LV contractility, RV end-diastolic pressure, cardiac index, and fluid balance.

Conditions

Interventions

TypeNameDescription
DRUGNorepinephrineintervention with norepinephrine to reach a MAP of 85 mmHg

Timeline

Start date
2019-03-01
Primary completion
2020-05-15
Completion
2020-05-25
First posted
2019-01-16
Last updated
2020-05-27

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03806582. Inclusion in this directory is not an endorsement.